// App-Quantinova.ai

2547 : Molecular insights into OGG1 gene, a modifier of cancer risk in BRCA1 and BRCA2 mutations carriers

Researchers

Presenter

  • Carlos Benitez-Buelga

Principal Investigators

  • Tereza Vaclova

  • Maria Sofia Ferreira

  • Nora Soberon

  • Maria Antonia Blasco

  • Ana Osorio

  • Javier Benitez

Medical Centers

  • Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain

  • Human Genetics Group, Spanish National Cancer Research Center (CNIO), Madrid, Spain

  • Human Genetics Group, Spanish National Cancer Research Center (CNIO), and Spanish Network on Rare Diseases (CIBERER), Madrid, Spain.

Locations

  • Spain

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • N-glycosylase/DNA lyase

  • Breast cancer type 1 susceptibility protein

  • Breast cancer type 2 susceptibility protein

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Spanish Ministry of Health

Result

  • N/A